CSTL

Castle Biosciences

32.93

+0.61+1.89%

After Hours: 32.93 0.00 0.00%16:15 08/20 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE32.41/32.32

TODAY RANGE32.41-34.01

VOL322.91K

MARKET CAP1.01B

52 WEEK RANGE17.72-44.28

AVG VOL (3M)399.53K

% TURNOVER1.06%

TURNOVER--

P/E (TTM)-50.6304

% RANGE4.92%

EPS(TTM)-0.6504

P/E(FORWARD)-25.5271

P/B2.137

BVPS15.41

DIVIDEND--

P/S2.840

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP967.52M

SHARES OUTSTANDING30.55M

NEXT EARNINGS11/02-11/06

FREE FLOAT29.38M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·1d ago
Castle Biosciences Insider Move Signals a Big Shift Behind the Scenes
TipRanks·08/10 00:28
Castle Biosciences Ups 2026 Outlook Amid Growth
NASDAQ·08/08 01:48
Castle Biosciences (CSTL) Q2 2026 Earnings Call Transcript
TipRanks·08/04 11:06
Castle Biosciences price target raised to $44 from $40 at BTIG
TipRanks·08/03 11:45
Castle Biosciences Reaffirmed at Buy as Strong Q2 and Raised 2026 Outlook Support 43% Upside to Unchanged $40 Price Target
Dow Jones·08/03 10:45
Castle Biosciences Price Target Raised to $44.00/Share From $40.00 by BTIG
Dow Jones·08/03 10:45
Castle Biosciences Is Maintained at Buy by BTIG
TipRanks·07/31 12:56
Castle Biosciences price target raised to $57 from $52 at Lake Street
TipRanks·07/31 11:21
Castle Biosciences price target lowered to $36 from $43 at Baird
NASDAQ·07/30 22:04
Castle Biosciences Q2 Earnings Call Highlights
TipRanks·07/30 21:10
Castle Biosciences Lifts 2026 Outlook After Q2 Growth
TipRanks·07/30 20:17
Castle Biosciences reports Q2 EPS (7c), consensus (41c)
TipRanks·07/30 20:16
Castle Biosciences raises 2026 revenue view to $365M-$375M from $345M-$355M
Dow Jones·07/30 20:05
*Castle Biosciences 2Q Rev $103.5M >CSTL
Dow Jones·07/30 20:05
*Castle Biosciences 2Q Loss/Shr 7c >CSTL

Same Industry

Name/Symbol

Change%

Price

CSTL

Atrion Corp

ATRI

0.00%

459.92

IDEXX Laboratories

IDXX

+1.79%

555.89

Cencora Inc.

COR

+0.73%

316.13

Teleflex Inc

TFX

-0.86%

131.92

Stryker Corp

SYK

-0.55%

339.21

West Pharm Svcs

WST

+0.94%

349.42

Ufp Technologies

UFPT

+0.10%

321.63

Shockwave Medical, Inc.

SWAV

0.00%

334.75

Cooper

COO

-0.56%

76.17

BDXB

Becton Dickinson & Co

BDX

-0.72%

180.77

Utah Med Prods

UTMD

-1.11%

70.21

Align Technology Inc

ALGN

-4.91%

172.41

Henry Schein, Inc.

HSIC

-0.56%

89.02

Repligen

RGEN

-2.23%

165.27

Ge Healthcare Technologies Inc

GEHC

-0.14%

73.69

Abbott Labs

ABT

+2.09%

112.68

Conmed Corp

CNMD

+1.18%

50.41

Medtronic

MDT

-0.71%

90.62

Zimmer Biomet

ZBH

-2.43%

98.20

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.